Hints and tips:
Related Special Reports
...Corporate records show that Swiss-registered Paramount SA entered voluntary liquidation earlier this month. Troost founded Paramount SA in 2017....
...It is good for fund managers who want to use this [information] in marketing through brokers,” said Lance Dial, a partner at the K&L Gates law firm....
...Inc., a footwear company based in California, agreed to settle charges for failing to disclose payments for the benefit of its executives and their immediate family members....
...He still loved advertising, he assured me, and he is still working at W+K....
...Congress has passed two reform packages in the past five years aimed at making 401(k) and other retirement plans more comprehensive and effective....
...management of Altice’s heavily indebted French telecoms business badly burned bondholders last month, when they carefully explained on a results call that, because modern-day debt covenants have more holes than Swiss...
...“material weaknesses in the company’s internal controls related to internal loan review, resulting from ineffective oversight, risk assessment and monitoring”, causing a delay in the release of its 10-K...
...The Swiss case was the last criminal case outstanding against Bouvier....
...The other crisis-hit Swiss lender Philipp Rickenbacher was installed as chief executive of Julius Baer four and a half years ago with a simple objective: play it safe....
...But the A class shares trade at $634,030 — meaning a single share is worth four times as much as the average 401(k) plan on Vanguard’s numbers. Sure, no splits means missing out on froth....
...Even so, Rich Kerr, an attorney who co-leads the digital assets team at law firm K&L Gates, is optimistic that the new crop of spot bitcoin ETFs might be easier to approve than expected....
...Meanwhile, a 2022-vintage 20F by Swiss group VectivBio Holding claims: The information shown is as of December 31, 2022 and is based upon a Schedule 13G filed on February 31, 2023....
...One of the most imposing pieces at the Nomad St Moritz design fair, held last weekend at the Swiss resort town, was, if by sheer bulk alone, a fully made bed....
...Many recordkeepers still do not offer ETFs in 401(k) accounts because of operational issues. But it is not just ETFs that are taking money from mutual funds....
...EQT-backed dermatology company Galderma also announced its intention to raise $2.3bn in an IPO on the Swiss stock exchange, at a valuation of about $20bn....
...At Frieze London in 2021 the gallery showed “Ru k’ ox k’ob’el jun ojer etemab’el” (“The Echo of an Ancient Form of Knowledge”) by Edgar Calel, an Indigenous Maya Kaqchikel artist, which features two dozen...
...The Milnes chose Crans-Montana over other Swiss resorts such as Verbier, Villars and Nendaz because they say it’s a better year-round town, with golf and high-end shopping....
...The Swiss dermatology giant raised SFr2bn ($2.2bn) in the biggest European float since Porsche’s debut two years ago....
...The abrupt closure in the midst of the ski season severely dented the resort’s reputation as a reliable Swiss tourism destination....
...The case — in which oligarch Dmitry Rybolovlev has accused Sotheby’s of helping Swiss art dealer Yves Bouvier overcharge him by approximately $1bn on numerous purchases over a decade — has captivated the...
...Job moves Julius Baer’s chief executive Philipp Rickenbacher is leaving the Swiss bank as it prepares to write off $700mn in loans to crisis-hit Austrian property group Signa....
...I’m not here to tell you who is right and who is wrong,” said Azar, who cut his teeth in the discreet world of Swiss private banking....
...Rybolovlev is seeking $377mn in damages from Sotheby’s in the lawsuit, accusing it of being complicit in a years-long scheme by a Swiss art dealer, Yves Bouvier, to sell him hundreds of millions of dollars...
...Rybolovlev’s lawyers argued Sotheby’s knew, or should have known, that Swiss art dealer Yves Bouvier was “flipping” art to Rybolovlev for far more than he paid for it, without disclosing that he was not...
...The Swiss company will acquire the rights to develop and manufacture Telavant’s potential drug for inflammatory bowel disease, which affects almost 8mn people worldwide....
International Edition